(Q39497802)

English

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Kylmälä T

1

1 reference

Europe PubMed Central

12 September 2017

Tammela T

2

1 reference

Europe PubMed Central

12 September 2017

Risteli L

3

1 reference

Europe PubMed Central

12 September 2017

Risteli J

4

1 reference

Europe PubMed Central

12 September 2017

Taube T

5

1 reference

Europe PubMed Central

12 September 2017

Elomaa I

6

1 reference

Europe PubMed Central

12 September 2017

publication date

1 January 1993

1 reference

Europe PubMed Central

12 September 2017

European Journal of Cancer

1 reference

Europe PubMed Central

12 September 2017

29A

1 reference

Europe PubMed Central

12 September 2017

6

1 reference

Europe PubMed Central

12 September 2017

821-825

1 reference

Europe PubMed Central

12 September 2017

Prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal Therapy of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the prostate. Hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced prostatic cancer. Evaluation of response parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalised increase in bone resorption in carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperparathyroidism in metastases of prostatic carcinoma: a biochemical, hormonal and histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980417-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(05)80417-4

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39497802&oldid=1832116660"